Journals / Turkish Journal of Anaesthesiology and Reanimation / 2015 / Cilt: 43 - Sayı: 6

Primary Graft Dysfunction after Lung Transplantation

Akciğer Transplantasyonu Sonrası Primer Greft Disfonksiyonu

Pages
418–423
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, recent updates in epidemiology, pathophysiology, molecular and genetic biomarkers and technical developments affecting PGD are described

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Primary graft dysfunction (PGD) is a severe form of acute lung injury that is a major cause of early morbidity and mortality encountered after lung transplantation.
📊
Key Findings & Data:PGD is diagnosed by pulmonary oedema with diffuse alveolar damage that manifests clinically as progressive hypoxemia with radiographic pulmonary infiltrates.
💡
Conclusion & Impact:In this review, recent updates in epidemiology, pathophysiology, molecular and genetic biomarkers and technical developments affecting PGD are described
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Primary graft dysfunction (PGD) is a severe form of acute lung injury that is a major cause of early morbidity and mortality encountered after lung transplantation. PGD is diagnosed by pulmonary oedema with diffuse alveolar damage that manifests clinically as progressive hypoxemia with radiographic pulmonary infiltrates. Inflammatory and immunological response caused by ischaemia and reperfusion is important with regard to pathophysiology. PGD affects short- and long-term outcomes, the donor organ is the leading factor affecting these adverse ramifications. To minimize the risk of PGD, reduction of lung ischaemia time, reperfusion optimisation, prostaglandin level regulation, haemodynamic control, hormone replacement therapy, ventilator management are carried out; for research regarding donor lung preparation strategies, certain procedures are recommended. In this review, recent updates in epidemiology, pathophysiology, molecular and genetic biomarkers and technical developments affecting PGD are described

Özet

Primer greft disfonksiyonu (PGD), akciğer nakli sonrası karşılaşı- lan, mortalite ve morbiditenin en önemli nedeni olan, akut akci- ğer hasarının ciddi bir formudur. Yaygın alveol hasarı ve akciğer ödemi nedeniyle progresif hipoksemiye yol açan radyolojik olarak pulmoner infiltrasyon ile karakterize bir klinik tablodur. İskemi ve reperfüzyon nedeniyle oluşan inflamatuvar ve immünolojik ya- nıt patofizyolojide önemli rol oynamaktadır. PGD riskini en aza indirmek amacıyla; iskemi süresinin azaltılması, reperfüzyonun fects short- and long-term outcomes, the donor organ is the leading optimizasyonu, prostaglandin seviyelerinin düzenlenmesi, hemo- factor affecting these adverse ramifications. To minimize the risk of dinaminin kontrolü, hormon replasmanı, ventilatör yönetimi ve donör akciğeri hazırlama stratejileri üzerinde yapılan araştırma- larda bazı prosedürler önerilmektedir. Bu derlemede PGD'nin replacement therapy, ventilator management are carried out; for epidemiyolojisi, patofizyolojisi, moleküler ve genetik belirteçler research regarding donor lung preparation strategies, certain pro- ile teknik gelişmeler irdelenecektir

🔖

Cite This Article

ALTUN, G. T., ARSLANTAŞ, M. K., CİNEL, İ. (2015). Primary Graft Dysfunction after Lung Transplantation. Turkish Journal of Anaesthesiology and Reanimation, Cilt: 43 - Sayı: 6, 418–423. https://ajindex.com/articles/370387

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Meyer KC. Lung transplantation. F1000Prime Rep 2013
  2. [CrossRef] 2. Lee JC, Christie JD. Primary graft dysfunction. Clin Chest Med 2011
  3. [CrossRef] 3. Christie JD, Kotloff RM, Ahya VN, Tino G, Pochettino A, Gaughan C, et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005
  4. [CrossRef] 4. Diamond JM, Lee JC, Kawut SM, Shah RJ, Localio AR, Bellamy SL, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013
  5. [CrossRef] 5. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005
  6. [CrossRef] 6. Christie JD, Kotloff RM, Pochettino A, Arcasoy SM, Rosengard BR, Landis JR, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003
  7. [CrossRef] 7. Thabut G, Vinatier I, Stern JB, Leseche G, Loirat P, Fournier M, et al. Primary graft failure following lung transplantation: predictive factors of mortality. Chest 2002
  8. [CrossRef] 8. Prekker ME, Nath DS, Walker AR, Johnson AC, Hertz MI, Herrington CS, et al. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant 2006
  9. [CrossRef] 9. Whitson BA, Prekker ME, Herrington CS, Whelan TP, Radosevich DM, Hertz MI, et al. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant 2007
  10. [CrossRef] 10. De Perrot M, Bonser RS, Dark J, Kelly RF, McGiffin D, Menza R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers. J Heart Lung Transplant 2005
  11. [CrossRef] 11. Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant 2011
  12. [CrossRef] 12. Cinel I, Opal SM. Molecular biology of inflammation and sepsis: a primer. Crit Care Med 2009
  13. [CrossRef] 13. De Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care M